Jeisys Medical Inc. (287410.KQ)
KRW 12900.0
(0.16%)
KRW 12900.0
(0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 143.02 Billion | 116.54 Billion | 81.29 Billion | 47.82 Billion |
| Cost of Revenue | 44.05 Billion | 36.97 Billion | 24.64 Billion | 14.08 Billion |
| Gross Profit | 98.97 Billion | 79.57 Billion | 56.64 Billion | 33.73 Billion |
| Operating Expenses | 62.65 Billion | 45.53 Billion | 33.04 Billion | 22.7 Billion |
| Selling, General and Administrative Expenses | 28.61 Billion | 18.49 Billion | 12.54 Billion | 6.99 Billion |
| Research and Development Expenses | 2.74 Billion | 2.5 Billion | 2.19 Billion | 1.13 Billion |
| Other Expenses | 31.29 Billion | 47.21 Million | -10.49 Billion | -1.9 Billion |
| Cost and Expenses | 106.71 Billion | 82.51 Billion | 57.69 Billion | 36.79 Billion |
| Operating Income | 36.31 Billion | 34.03 Billion | 23.6 Billion | 11.03 Billion |
| Interest Expense | 222.43 Million | 391.24 Million | 387.98 Million | 980.56 Million |
| Income Tax Expense | 10.39 Billion | 6.87 Billion | -667.11 Million | 1.06 Billion |
| Earnings before Tax | 35.49 Billion | 33.88 Billion | 13.09 Billion | 8.21 Billion |
| Net Income | 24.8 Billion | 27.12 Billion | 13.59 Billion | 7.54 Billion |
| Earnings Per Share Basic | 328.00 | 381.00 | 195.00 | -5.00 |
| Earnings Per Share Diluted | 322.00 | 370.00 | 177.00 | -5.00 |
| Weighted Average Shares Outstanding | 75.61 Million | 71.2 Million | 69.7 Million | 4.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 77.01 Million | 73.32 Million | 76.78 Million | 4.23 Million |
| Gross Margin | 0.69 | 0.68 | 0.70 | 0.71 |
| EBIT Margin | 0.28 | 0.32 | 0.19 | 0.23 |
| Profit Margin | 0.17 | 0.23 | 0.17 | 0.16 |
| EBITDA | 40.57 Billion | 37.31 Billion | 26.07 Billion | 13.17 Billion |
| Earnings Before Tax Margin | 0.25 | 0.29 | 0.29 | 0.23 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 45.1 Billion | 43.95 Billion | 39.65 Billion | 143.02 Billion | 39.1 Billion | 35.16 Billion |
| Cost of Revenue | 13.59 Billion | 13.13 Billion | 11.97 Billion | 44.05 Billion | 12.01 Billion | 10.51 Billion |
| Gross Profit | 31.51 Billion | 30.82 Billion | 27.68 Billion | 98.97 Billion | 27.09 Billion | 24.64 Billion |
| Operating Expenses | -21.26 Billion | 21.96 Billion | 18.85 Billion | 62.65 Billion | 16.87 Billion | 14.99 Billion |
| Selling, General and Administrative Expenses | 21.26 Billion | 11.55 Billion | 10.06 Billion | - | 8.94 Billion | 5.62 Billion |
| Research and Development Expenses | 1.1 Billion | 1.09 Billion | 499.34 Million | - | 693.44 Million | 766.44 Million |
| Other Expenses | -42.52 Billion | 34.21 Million | 7.02 Million | 118.38 Million | 19.72 Million | 19.72 Million |
| Cost and Expenses | 13.59 Billion | 35.09 Billion | 30.82 Billion | 106.71 Billion | 28.88 Billion | 25.51 Billion |
| Operating Income | 10.25 Billion | 8.85 Billion | 8.82 Billion | 36.31 Billion | 10.22 Billion | 9.64 Billion |
| Interest Expense | - | 83.31 Million | -30.8 Million | 222.43 Million | 64.29 Million | 94.75 Million |
| Income Tax Expense | 1.26 Billion | 1.71 Billion | 4.79 Billion | 10.39 Billion | 2.07 Billion | 1.76 Billion |
| Earnings before Tax | 10.5 Billion | 8.74 Billion | 8.91 Billion | 35.49 Billion | 10.12 Billion | 8.01 Billion |
| Net Income | 9.12 Billion | 6.92 Billion | 3.96 Billion | 24.8 Billion | 7.94 Billion | 6.2 Billion |
| Earnings Per Share Basic | 121.01 | 91.00 | 51.86 | - | 104.00 | 81.00 |
| Earnings Per Share Diluted | 121.01 | 90.00 | 49.27 | - | 103.00 | 80.00 |
| Weighted Average Shares Outstanding | 75.43 Million | 76.1 Million | 80.49 Million | 75.61 Million | 76.4 Million | 76.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.43 Million | 76.94 Million | 77.06 Million | 77.01 Million | 77.53 Million | 77.62 Million |
| Gross Margin | 0.70 | 0.70 | 0.70 | 0.69 | 0.69 | 0.70 |
| EBIT Margin | 0.70 | 0.23 | 0.25 | - | 0.29 | 0.26 |
| Profit Margin | 0.20 | 0.16 | 0.10 | 0.17 | 0.20 | 0.18 |
| EBITDA | 31.51 Billion | 10.05 Billion | 10.1 Billion | - | 11.39 Billion | 9.18 Billion |
| Earnings Before Tax Margin | 0.23 | 0.20 | 0.22 | 0.25 | 0.26 | 0.27 |
NSPR
PPS
ADGCF
RXRX
603606
MANAPPURAM